The immunoglobulin CH1 constant region modulates antigen binding affinity and functional activities of the broadly neutralizing 2F5 HIV specific antibody
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The immunoglobulin CH1 constant region modulates antigen binding affinity and functional activities of the broadly neutralizing 2F5 HIV specific antibody ; volume:7 ; number:1 ; day:11 ; month:5 ; year:2010 ; pages:1 ; date:5.2010
Retrovirology ; 7, Heft 1 (11.5.2010), 1, 5.2010
- Creator
-
Tudor, Daniela
- Contributor
-
Drillet, Anne-Sophie
Schwartz-Cornil, Isabelle
Shen, Ruizhong
Smith, Phillip D.
Bomsel, Morgane
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-7-S1-P23
- URN
-
urn:nbn:de:1111-2016080714107
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tudor, Daniela
- Drillet, Anne-Sophie
- Schwartz-Cornil, Isabelle
- Shen, Ruizhong
- Smith, Phillip D.
- Bomsel, Morgane
- SpringerLink (Online service)
Other Objects (12)
Broadly Neutralizing Antibodies for HIV Eradication
Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies
Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Design clues from functional constraints and broadly neutralizing antibodies
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Identification of a novel broadly neutralizing antibody targeting HIV-1
Broadly Neutralizing Antibodies for HIV Eradication
Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies
Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Design clues from functional constraints and broadly neutralizing antibodies
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Identification of a novel broadly neutralizing antibody targeting HIV-1
Broadly Neutralizing Antibodies for HIV Eradication
Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies
Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Design clues from functional constraints and broadly neutralizing antibodies
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection